Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Thomas McCourt — FY2025 total compensation $1,948,390

Thomas McCourt is Chief Executive Officer of Ironwood Pharmaceuticals Inc (IRWD). The company reported total compensation of $1,948,390 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$867,568
Bonus$0
Stock awards$411,696
Option awards$0
Non-equity incentive plan$650,676
Pension and non-qualified deferred compensation$0
All other compensation$18,450
Total$1,948,390

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Ironwood Pharmaceuticals Inc filed April 28, 2026, accession 0001104659-26-050325.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025Chief Executive Officer$867,568$0$411,696$0$650,676$0$18,450$1,948,390
FY2024Chief Executive Officer$867,568$4,722,733$455,473$37,857$6,083,631
FY2021Chief Executive Officer$732,053$143,300$7,236,498$680,063$18,090$8,810,004
FY2020Chief Executive Officer$576,120$2,465,327$357,409$11,040$3,409,896
FY2019Chief Executive Officer$511,250$0$1,760,143$2,370,159$454,272$0$8,502$5,104,326

Totals as disclosed in each year's own compensation disclosure for Ironwood Pharmaceuticals Inc.

04

The other named executive officers of Ironwood Pharmaceuticals Inc

Named executive officerRoleFY2025 total
Thomas McCourt this pageChief Executive Officer$1,948,390
Tammi GaskinsSenior Vice President, Chief Commercial Officer$1,215,389
Gregory MartiniSenior Vice President, Chief Financial Officer$1,211,133

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Ironwood Pharmaceuticals Inc compensation brief.

05

The company page

Thomas McCourt's compensation sits inside Ironwood Pharmaceuticals Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Ironwood Pharmaceuticals Inc (IRWD) compensation brief